Literature DB >> 34694522

Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience.

Bojun Wei1, Teng Zhao2, Hong Shen2, Mulan Jin3, Quan Zhou4, Xing Liu2, Jiacheng Wang2, Qian Wang2.   

Abstract

BACKGROUND: Parathyroid carcinoma (PC) is a rare malignancy that is difficult to eradicate completely after recurrence. We assessed the efficiency of extended en bloc resection (EEBR) in the management of recurrent or persistent PC.
METHODS: In this observational cohort study, 31 patients who underwent reoperations for recurrent or persistent PC were enrolled after 2-9 surgeries by other medical teams. EEBRs, which provided the oncologic resection by removing all possible tumor-bearing scar tissues, were adopted in 25 patients. The other 6 with gross infiltration into the upper aerodigestive tract (UAT) underwent less radical procedures for unwillingness to sacrifice laryngeal function.
RESULTS: The 5-year overall survival (OS) rate after EEBR was 59.6% compared with 16.7% after less radical procedures, with an improved median expected survival time of 90.0 months compared with 13.0 months after local excision. EEBR exhibited a favorable local control of relapses in 84.0% of patients after a median follow-up period of 27.0 months, 40.0% even achieved disease-free survival, although 56.0% had subsequent distant metastases (DMs) and suffered a worse 5-year OS of 36.7% in contrast with 100.0% in the absence of DM (p = 0.011). UAT invasion, rather than age, number of previous operations, or preoperative PTH levels, was the unique independent factor associated with both DM (HR = 5.466, p = 0.006) and mortality (HR = 7.606, p = 0.011).
CONCLUSION: EEBRs provide better outcomes than other conventional surgical approaches and might offer a second chance of cure for patients with recurrent or persistent PC in the absence of DM.
© 2021. Society of Surgical Oncology.

Entities:  

Mesh:

Year:  2021        PMID: 34694522     DOI: 10.1245/s10434-021-10962-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

1.  Hsa_circ_0005729 enhances accuracy in diagnosing parathyroid carcinoma.

Authors:  Qian Wang; Jiacheng Wang; Yunhui Xin; Ziyang He; Xiang Zhou; Xing Liu; Teng Zhao; Lihan He; Hong Shen; Mulan Jin; Bojun Wei
Journal:  Endocr Connect       Date:  2022-02-16       Impact factor: 3.335

2.  Patterns and Predictors of Cervical Lymph Node Metastasis in Parathyroid Carcinoma.

Authors:  Ya Hu; Ming Cui; Xiaoyan Chang; Ou Wang; Tianqi Chen; Jinheng Xiao; Mengyi Wang; Surong Hua; Quan Liao
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.